JP2018523644A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018523644A5 JP2018523644A5 JP2018502356A JP2018502356A JP2018523644A5 JP 2018523644 A5 JP2018523644 A5 JP 2018523644A5 JP 2018502356 A JP2018502356 A JP 2018502356A JP 2018502356 A JP2018502356 A JP 2018502356A JP 2018523644 A5 JP2018523644 A5 JP 2018523644A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- pharmaceutically acceptable
- acceptable salt
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITUB2015A002860A ITUB20152860A1 (it) | 2015-08-04 | 2015-08-04 | Selezionata amide dell?acido ?-idrossibutirrico e suoi usi nel trattamento dell?abuso da alcool |
| IT102015000041820 | 2015-08-04 | ||
| PCT/EP2016/068517 WO2017021438A1 (en) | 2015-08-04 | 2016-08-03 | SELECTED AMIDE OF γ -HYDROXYBUTYRIC ACID AND USES THEREOF IN THE TREATMENT OF ALCOHOL MISUSE |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018523644A JP2018523644A (ja) | 2018-08-23 |
| JP2018523644A5 true JP2018523644A5 (enExample) | 2019-08-15 |
| JP6832336B2 JP6832336B2 (ja) | 2021-02-24 |
Family
ID=54542363
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018502356A Expired - Fee Related JP6832336B2 (ja) | 2015-08-04 | 2016-08-03 | アルコール乱用の治療におけるγ−ヒドロキシ酪酸の選択されたアミドおよびその使用 |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US10336687B2 (enExample) |
| EP (1) | EP3331853B1 (enExample) |
| JP (1) | JP6832336B2 (enExample) |
| KR (1) | KR102817897B1 (enExample) |
| CN (1) | CN108026029B (enExample) |
| AU (1) | AU2016302869B2 (enExample) |
| CA (1) | CA2994599C (enExample) |
| CL (1) | CL2018000282A1 (enExample) |
| CO (1) | CO2018002428A2 (enExample) |
| DK (1) | DK3331853T3 (enExample) |
| EA (1) | EA033769B9 (enExample) |
| ES (1) | ES2776628T3 (enExample) |
| GE (1) | GEP20207107B (enExample) |
| IL (1) | IL257314B (enExample) |
| IT (1) | ITUB20152860A1 (enExample) |
| MX (1) | MX2018001239A (enExample) |
| MY (1) | MY185942A (enExample) |
| PH (1) | PH12018550008A1 (enExample) |
| PL (1) | PL3331853T3 (enExample) |
| PT (1) | PT3331853T (enExample) |
| SM (1) | SMT202000337T1 (enExample) |
| UA (1) | UA121994C2 (enExample) |
| WO (1) | WO2017021438A1 (enExample) |
| ZA (1) | ZA201801402B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3066711A1 (en) | 2017-07-31 | 2019-02-07 | Novartis Ag | Use of mavoglurant in the reduction of cocaine use or in preventing relapse into cocaine use |
| CN110891564A (zh) | 2017-07-31 | 2020-03-17 | 诺华股份有限公司 | 玛沃谷兰在减少酒精使用或在预防复用酒精中的用途 |
| CN113185403A (zh) * | 2021-07-02 | 2021-07-30 | 山东国邦药业有限公司 | 一种甲醚制备环丙胺中间体环丙甲酸甲酯的方法 |
| WO2023126076A1 (en) * | 2022-01-03 | 2023-07-06 | Laboratorio Farmaceutico C.T. S.R.L. | Medical use of an amide of y-hydroxybutyric acid in the treatment of fragile x syndrome |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1283782B1 (it) * | 1996-08-09 | 1998-04-30 | Ct Lab Farm Srl | Uso di ammidi dell'acido gamma-idrossibutirrico nel trattamento di tossicodipendenze,ed in particolare sell'alcolismo |
-
2015
- 2015-08-04 IT ITUB2015A002860A patent/ITUB20152860A1/it unknown
-
2016
- 2016-08-03 MY MYPI2018700405A patent/MY185942A/en unknown
- 2016-08-03 MX MX2018001239A patent/MX2018001239A/es active IP Right Grant
- 2016-08-03 US US15/750,047 patent/US10336687B2/en active Active
- 2016-08-03 EP EP16791313.6A patent/EP3331853B1/en active Active
- 2016-08-03 UA UAA201801726A patent/UA121994C2/uk unknown
- 2016-08-03 SM SM20200337T patent/SMT202000337T1/it unknown
- 2016-08-03 EA EA201890419A patent/EA033769B9/ru not_active IP Right Cessation
- 2016-08-03 CN CN201680045364.9A patent/CN108026029B/zh not_active Expired - Fee Related
- 2016-08-03 KR KR1020187006231A patent/KR102817897B1/ko active Active
- 2016-08-03 ES ES16791313T patent/ES2776628T3/es active Active
- 2016-08-03 DK DK16791313.6T patent/DK3331853T3/da active
- 2016-08-03 PT PT167913136T patent/PT3331853T/pt unknown
- 2016-08-03 WO PCT/EP2016/068517 patent/WO2017021438A1/en not_active Ceased
- 2016-08-03 AU AU2016302869A patent/AU2016302869B2/en not_active Ceased
- 2016-08-03 PL PL16791313T patent/PL3331853T3/pl unknown
- 2016-08-03 JP JP2018502356A patent/JP6832336B2/ja not_active Expired - Fee Related
- 2016-08-03 CA CA2994599A patent/CA2994599C/en active Active
- 2016-08-03 GE GEAP201614717A patent/GEP20207107B/en unknown
-
2018
- 2018-01-31 CL CL2018000282A patent/CL2018000282A1/es unknown
- 2018-02-01 IL IL257314A patent/IL257314B/en active IP Right Grant
- 2018-02-02 PH PH12018550008A patent/PH12018550008A1/en unknown
- 2018-02-28 ZA ZA2018/01402A patent/ZA201801402B/en unknown
- 2018-03-02 CO CONC2018/0002428A patent/CO2018002428A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013537203A5 (enExample) | ||
| JP2010138190A5 (enExample) | ||
| JP2018523644A5 (enExample) | ||
| JP2011524422A5 (enExample) | ||
| JP2013032389A5 (enExample) | ||
| JP2017508798A (ja) | ヒストンリジン特異的デメチラーゼ（ｌｓｄ１）およびヒストンデアセチラーゼ（ｈｄａｃ）の阻害剤 | |
| JP2017531038A5 (enExample) | ||
| JP2012255002A5 (enExample) | ||
| JP2009143956A5 (enExample) | ||
| JP2017533968A5 (enExample) | ||
| JP2008195730A5 (enExample) | ||
| JP2007508361A5 (enExample) | ||
| JP2012515219A5 (enExample) | ||
| KR20170039275A (ko) | 인플루엔자 바이러스 감염에 사용하기 위한 인돌 | |
| JP2010504343A5 (enExample) | ||
| EP3006431B1 (en) | Tizoxanide carbamate and pharmaceutical use thereof | |
| JP2016537346A5 (enExample) | ||
| JP2015505301A5 (enExample) | ||
| JP2015508092A5 (enExample) | ||
| JP2014505107A5 (enExample) | ||
| JP2015521156A5 (enExample) | ||
| RU2014100744A (ru) | Лечение респираторных нарушений с помощью trpa1 антагонистов | |
| JP2016529315A5 (enExample) | ||
| JP2019520344A5 (enExample) | ||
| JP2017538767A5 (enExample) |